Comparative genomics of 26 complete circular genomes of 18 different serotypes of Actinobacillus pleuropneumoniae
暂无分享,去创建一个
[1] P. Langford,et al. Proposal of Actinobacillus pleuropneumoniae serovar 19, and reformulation of previous multiplex PCRs for capsule-specific typing of all known serovars. , 2021, Veterinary microbiology.
[2] K. Waldmann,et al. Sero- and apx-typing of German Actinobacillus pleuropneumoniae field isolates from 2010 to 2019 reveals a predominance of serovar 2 with regular apx-profile , 2021, Veterinary Research.
[3] Gregory J Tsongalis,et al. Third-Generation Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing , 2019, Journal of Clinical Microbiology.
[4] Adina R. Bujold,et al. Investigation of putative invasion determinants of Actinobacillus species using comparative genomics. , 2019, Genomics.
[5] V. Perreten,et al. Comparative Genomics of the First and Complete Genome of “Actinobacillus porcitonsillarum” Supports the Novel Species Hypothesis , 2018, International journal of genomics.
[6] Claude Thermes,et al. The Third Revolution in Sequencing Technology. , 2018, Trends in genetics : TIG.
[7] D. Maskell,et al. Comparative sequence analysis of the capsular polysaccharide loci of Actinobacillus pleuropneumoniae serovars 1–18, and development of two multiplex PCRs for comprehensive capsule typing , 2018, Veterinary microbiology.
[8] W. Jachymek,et al. Antigens of Actinobacillus pleuropneumoniae and their use in the design of vaccines, especially glycoconjugates , 2018, Postępy Higieny i Medycyny Doświadczalnej.
[9] P. Langford,et al. Update on Actinobacillus pleuropneumoniae—knowledge, gaps and challenges , 2018, Transboundary and emerging diseases.
[10] A. Loera-Muro,et al. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae. , 2018, Veterinary microbiology.
[11] D. Maskell,et al. Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis , 2018, Veterinary microbiology.
[12] E Trees,et al. Next-generation sequencing technologies and their application to the study and control of bacterial infections. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] A. Ramette,et al. Heterogeneous Genetic Location of mcr-1 in Colistin-Resistant Escherichia coli Isolates from Humans and Retail Chicken Meat in Switzerland: Emergence of mcr-1-Carrying IncK2 Plasmids , 2017, Antimicrobial Agents and Chemotherapy.
[14] Ryan R. Wick,et al. Completing bacterial genome assemblies with multiplex MinION sequencing , 2017, bioRxiv.
[15] James Hadfield,et al. Phandango: an interactive viewer for bacterial population genomics , 2017, bioRxiv.
[16] Roy R. Chaudhuri,et al. Whole Genome Sequencing for Surveillance of Antimicrobial Resistance in Actinobacillus pleuropneumoniae , 2017, Front. Microbiol..
[17] David W. Russell,et al. Isolation of High-molecular-weight DNA from Mammalian Cells Using Proteinase K and Phenol. , 2017, CSH protocols.
[18] P. Langford,et al. A Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay , 2017, Journal of Clinical Microbiology.
[19] Ryan R. Wick,et al. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads , 2016, bioRxiv.
[20] Dmitry Antipov,et al. plasmidSPAdes: Assembling Plasmids from Whole Genome Sequencing Data , 2016, bioRxiv.
[21] D. Maskell,et al. Complete Genome Sequence of MIDG2331, a Genetically Tractable Serovar 8 Clinical Isolate of Actinobacillus pleuropneumoniae , 2016, Genome Announcements.
[22] M. Gottschalk. The challenge of detecting herds sub-clinically infected with Actinobacillus pleuropneumoniae. , 2015, Veterinary journal.
[23] Andrew J. Page,et al. Roary: rapid large-scale prokaryote pan genome analysis , 2015, bioRxiv.
[24] D. Maskell,et al. Multiplex PCR Assay for Unequivocal Differentiation of Actinobacillus pleuropneumoniae Serovars 1 to 3, 5 to 8, 10, and 12 , 2014, Journal of Clinical Microbiology.
[25] D. Leach,et al. Bacterial Genome Instability , 2014, Microbiology and Molecular Reviews.
[26] Yongqiang Yang,et al. Advances in nanopore sequencing technology. , 2013, Journal of nanoscience and nanotechnology.
[27] Ole Lund,et al. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. , 2013, The Journal of antimicrobial chemotherapy.
[28] R. Bashir,et al. Nanopore sensors for nucleic acid analysis. , 2011, Nature nanotechnology.
[29] M. Monteiro,et al. The lipopolysaccharide core of Actinobacillus suis and its relationship to those of Actinobacillus pleuropneumoniae. , 2011, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[30] B. Korczak,et al. A new variant of Actinobacillus pleuropneumoniae serotype 3 lacking the entire apxII operon , 2011, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.
[31] C. Friis,et al. Comparative profiling of the transcriptional response to iron restriction in six serotypes of Actinobacillus pleuropneumoniae with different virulence potential , 2010, BMC Genomics.
[32] P. Langford,et al. Prevalence of Actinobacillus pleuropneumoniae serovars in England and Wales , 2010, Veterinary Record.
[33] Yongxiang Zhang,et al. Pan-genome sequence analysis using Panseq: an online tool for the rapid analysis of core and accessory genomic regions , 2010, BMC Bioinformatics.
[34] Huanchun Chen,et al. Comparative Genomic Characterization of Actinobacillus pleuropneumoniae , 2010, Journal of bacteriology.
[35] L. Marraffini,et al. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea , 2010, Nature Reviews Genetics.
[36] Erik J. Sontheimer,et al. Self vs. non-self discrimination during CRISPR RNA-directed immunity , 2009, Nature.
[37] M. Jacques,et al. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies , 2008, Animal Health Research Reviews.
[38] V. Perreten,et al. Small multidrug resistance plasmids in Actinobacillus porcitonsillarum. , 2008, Plasmid.
[39] Wei Li,et al. Genome Biology of Actinobacillus pleuropneumoniae JL03, an Isolate of Serotype 3 Prevalent in China , 2008, PloS one.
[40] Simon J. Foote,et al. The Complete Genome Sequence of Actinobacillus pleuropneumoniae L20 (Serotype 5b) , 2007, Journal of bacteriology.
[41] M. Jacques,et al. Outer membrane proteome of Actinobacillus pleuropneumoniae: LC‐MS/MS analyses validate in silico predictions , 2007, Proteomics.
[42] B. Korczak,et al. Distribution of RTX toxin genes in strains of [Actinobacillus] rossii and [Pasteurella] mairii. , 2006, Veterinary microbiology.
[43] P. Kuhnert,et al. Characterization of the type I secretion system of the RTX toxin ApxII in "Actinobacillus porcitonsillarum". , 2005, Veterinary microbiology.
[44] E. Vinogradov,et al. Structural characterization of the antigenic capsular polysaccharide and lipopolysaccharide O-chain produced by Actinobacillus pleuropneumoniae serotype 15. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[45] M. Jacques. Surface polysaccharides and iron-uptake systems of Actinobacillus pleuropneumoniae. , 2004, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[46] H. van den Bosch,et al. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. , 2002, Veterinary microbiology.
[47] M. Jacques,et al. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity , 2000, Animal Health Research Reviews.
[48] P. Kuhnert,et al. Apx toxins in Pasteurellaceae species from animals. , 2000, Veterinary microbiology.
[49] V. Fussing. Genomic relationships of Actinobacillus pleuropnewmoniae serotype 2 strains evaluated by ribotyping, sequence analysis of ribosomal intergenic regions, and pulsed‐field gel electrophoresis , 1998, Letters in applied microbiology.
[50] J. Nielsen,et al. Comparison of virulence of different Actinobacillus pleuropneumoniae serotypes and biotypes using an aerosol infection model. , 1996, Veterinary microbiology.
[51] J. Nicolet,et al. Development of an efficient PCR method for toxin typing of Actinobacillus pleuropneumoniae strains. , 1995, Molecular and cellular probes.
[52] J. Frey. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. , 1995, Trends in microbiology.
[53] F. Haesebrouck,et al. Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. , 1993, Journal of general microbiology.
[54] F. Haesebrouck,et al. Comparative virulence of NAD-dependent and NAD-independent Actinobacillus pleuropneumoniae strains. , 1992, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.
[55] D. Williams,et al. Experimental reproduction of acute lesions of porcine pleuropneumonia with a haemolysin-deficient mutant of Actinobacillus pleuropneumoniae , 1991, Veterinary Record.
[56] Eugene V Koonin,et al. Annotation and Classification of CRISPR-Cas Systems. , 2015, Methods in molecular biology.